​

Prestige Consumer Healthcare (PBH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

PBH Stock Forecast

Prestige Consumer Healthcare (PBH) stock forecast, based on 15 Wall Street analysts, predicts a 12-month average price target of $89.50, with a high of $93.00 and a low of $86.00. This represents a 5.12% increase from the last price of $85.14.

$60 $67 $74 $81 $88 $95 High: $93 Avg: $89.5 Low: $86 Last Closed Price: $85.14

PBH Stock Rating

Prestige Consumer Healthcare stock's rating consensus is Buy, based on 15 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (86.67%), 2 Hold (13.33%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 15 0 2 13 Strong Sell Sell Hold Buy Strong Buy

PBH Price Target Upside V Benchmarks

TypeNameUpside
StockPrestige Consumer Healthcare5.12%
SectorHealthcare Stocks 24.81%
IndustryMedical Distribution Stocks9.13%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$89.50
Last Closing Price$85.14$85.14$85.14
Upside/Downside--5.12%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25-33-17
May, 25-34--7
Apr, 25-43-18
Mar, 25-43-18
Feb, 25-44--8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Nov 05, 2024SUsan AndersonCanaccord Genuity$86.00$74.5815.31%1.01%
Jun 21, 2024Linda Bolton WeiserD.A. Davidson$93.00$68.1336.50%9.23%
Nov 17, 2022Canaccord Genuity$71.00$58.3521.68%-16.61%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Nov 05, 2024Canaccord GenuityBuyBuyhold
Sep 23, 2024JefferiesBuyHolddowngrade
Nov 17, 2022Canaccord GenuityBuyinitialise
May 10, 2022JefferiesBuyupgrade
May 09, 2022OppenheimerOutperformupgrade

Financial Forecast

EPS Forecast

$-2 $-1 $0 $1 $2 $3 $4 $5 $6 Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27
Reported$3.28$4.09$-1.65$4.21---
Avg Forecast$3.23$4.03$4.18$4.33$4.44$4.78$5.05
High Forecast$3.26$4.07$4.22$4.37$4.49$4.82$5.18
Low Forecast$3.22$4.02$4.14$4.29$4.40$4.74$4.92
Surprise %1.55%1.49%-139.47%-2.77%---

Revenue Forecast

$900M $960M $1B $1B $1B $1B Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27
Reported$943.37M$1.09B$1.13B$1.13B---
Avg Forecast$936.15M$1.08B$1.12B$1.14B$1.13B$1.16B$1.18B
High Forecast$943.52M$1.09B$1.13B$1.14B$1.14B$1.17B$1.18B
Low Forecast$933.69M$1.08B$1.11B$1.13B$1.12B$1.15B$1.18B
Surprise %0.77%0.81%0.62%-0.92%---

Net Income Forecast

$-100M $-20M $60M $140M $220M $300M Mar 21 Mar 22 Mar 23 Mar 24 Mar 25 Mar 26 Mar 27
Mar 21Mar 22Mar 23Mar 24Mar 25Mar 26Mar 27
Reported$164.68M$205.38M$-82.31M$209.34M---
Avg Forecast$146.38M$161.90M$209.81M$-80.67M$224.15M$239.71M$253.40M
High Forecast$175.66M$194.28M$211.97M$-64.54M$225.25M$241.73M$259.79M
Low Forecast$117.10M$129.52M$207.87M$-96.81M$220.76M$237.70M$247.01M
Surprise %12.50%26.86%-139.23%-359.50%---

PBH Forecast FAQ

Is Prestige Consumer Healthcare stock a buy?

Prestige Consumer Healthcare stock has a consensus rating of Buy, based on 15 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Prestige Consumer Healthcare is a favorable investment for most analysts.

What is Prestige Consumer Healthcare's price target?

Prestige Consumer Healthcare's price target, set by 15 Wall Street analysts, averages $89.5 over the next 12 months. The price target range spans from $86 at the low end to $93 at the high end, suggesting a potential 5.12% change from the previous closing price of $85.14.

How does Prestige Consumer Healthcare stock forecast compare to its benchmarks?

Prestige Consumer Healthcare's stock forecast shows a 5.12% upside, underperforming the average forecast for the healthcare stocks sector (24.81%) and underperforming the medical distribution stocks industry (9.13%).

What is the breakdown of analyst ratings for Prestige Consumer Healthcare over the past three months?

  • June 2025: 0% Strong Buy, 42.86% Buy, 42.86% Hold, 0% Sell, 14.29% Strong Sell.
  • May 2025: 0% Strong Buy, 42.86% Buy, 57.14% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 50.00% Buy, 37.50% Hold, 0% Sell, 12.50% Strong Sell.

What is Prestige Consumer Healthcare’s EPS forecast?

Prestige Consumer Healthcare's average annual EPS forecast for its fiscal year ending in March 2025 is $4.44, marking a 5.46% increase from the reported $4.21 in 2024. Estimates for the following years are $4.78 in 2026, and $5.05 in 2027.

What is Prestige Consumer Healthcare’s revenue forecast?

Prestige Consumer Healthcare's average annual revenue forecast for its fiscal year ending in March 2025 is $1.13B, reflecting a 0.64% increase from the reported $1.13B in 2024. The forecast for 2026 is $1.16B, and $1.18B for 2027.

What is Prestige Consumer Healthcare’s net income forecast?

Prestige Consumer Healthcare's net income forecast for the fiscal year ending in March 2025 stands at $224.15M, representing an 7.07% increase from the reported $209.34M in 2024. Projections indicate $239.71M in 2026, and $253.4M in 2027.